Biotech firm Pnds Medical lands £370k investment
Published
Pnds Medical Ltd has closed an estimated £370k capital injection that values the business at approximately £2.9m. Based in London, the company is engaged in experimental development on biotechnology.
Incorporated in 2023, the startup focuses on biology research, bioinformatics, and cell and tissue culture and engineering. Its technical work also covers DNA/RNA, gene and RNA vectors, nanobiotechnology, and process biotechnology techniques, alongside the study of proteins and other molecules.
Financial records for the period ending 31 August 2025 show that the firm employed two people. This most recent funding (allotted in June) contributes to a total of £399.6k raised during 2026. This follows the previous year, when the entity secured £508.6k.
Contact the editorial team at editorial@fundingspotter.com